PTHS

Pelthos Therapeutics Inc. Common Stock (PTHS)

About Pelthos Therapeutics Inc. Common Stock (PTHS)

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.

Details

Daily high

$24.79

Daily low

$24.01

Price at open

$24.44

52 Week High

$37.50

52 Week Low

$18.19

Market cap

93.2M

Dividend yield

Volume

18,796

Avg. volume

43,778

P/E ratio

-.92

Pelthos Therapeutics Inc. Common Stock News